Larimar Therapeutics Inc (LRMR)
SG&A Expenses
$6.35M
Quarterly · Period ending: · USD
LRMR SG&A Expenses
Latest reported$6.35Mperiod ending
Latest reported$6.35Mperiod ending
LRMR Quarterly SG&A Expenses ($1.29M → $6.35M)
Quarterly SG&A Expenses
High-resolution chart · PNG
LRMR sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 6,351,000 | |
| 6,086,000 | |
| 4,645,000 | |
| 4,668,000 | |
| 4,424,000 | |
| 4,636,000 | |
| 4,555,000 | |
| 4,345,000 | |
| 4,917,000 | |
| 3,795,000 | |
| 3,514,000 | |
| 3,754,000 | |
| 3,745,000 | |
| 3,075,000 | |
| 3,221,000 | |
| 2,931,000 | |
| 3,043,000 | |
| 3,081,000 | |
| 2,794,000 | |
| 2,702,000 | |
| 3,441,000 | |
| 3,132,000 | |
| 3,822,000 | |
| 3,416,000 | |
| 2,492,000 | |
| 1,667,000 | |
| 752,000 | |
| 594,000 | |
| 576,000 | |
| 502 | |
| 3,234,000 | |
| 3,339,000 | |
| 3,351,000 | |
| 3,269,000 | |
| 2,447,000 | |
| 3,117,000 | |
| 3,008,000 | |
| 3,588,000 | |
| 3,200,000 | |
| 4,830,000 | |
| 4,899,000 | |
| 5,360,000 | |
| 5,540,000 | |
| 5,546,000 | |
| 5,084,000 | |
| 3,025,000 | |
| 2,285,000 | |
| 1,291,000 |